Drug Shortage Report for ATIVAN
| Report ID | 232288 |
| Drug Identification Number | 02041472 |
| Brand name | ATIVAN |
| Common or Proper name | Ativan 2mg Sublinguale |
| Company Name | PFIZER CANADA ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | LORAZEPAM |
| Strength(s) | 2MG |
| Dosage form(s) | TABLET |
| Route of administration | SUBLINGUAL SUBLINGUAL |
| Packaging size | Btl 1x100 |
| ATC code | N05BA |
| ATC description | ANXIOLYTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-07-26 |
| Estimated end date | |
| Actual end date | 2025-10-17 |
| Shortage status | Resolved |
| Updated date | 2025-10-18 |
| Company comments | Discontinuation posting showing discontinuation date of Oct-31-2025 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v17 | 2025-10-18 | English | Compare |
| v16 | 2025-10-17 | French | Compare |
| v15 | 2025-10-17 | English | Compare |
| v14 | 2025-01-03 | French | Compare |
| v13 | 2025-01-03 | English | Compare |
| v12 | 2024-10-03 | French | Compare |
| v11 | 2024-10-03 | English | Compare |
| v10 | 2024-07-27 | English | Compare |
| v9 | 2024-07-26 | French | Compare |
| v8 | 2024-07-26 | English | Compare |
| v7 | 2024-07-26 | English | Compare |
| v6 | 2024-07-19 | French | Compare |
| v5 | 2024-07-19 | English | Compare |
| v4 | 2024-07-04 | French | Compare |
| v3 | 2024-07-04 | English | Compare |
| v2 | 2024-07-04 | French | Compare |
| v1 | 2024-07-04 | English | Compare |
Showing 1 to 17 of 17